BRIZZI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.838
EU - Europa 5.711
AS - Asia 2.713
SA - Sud America 452
Continente sconosciuto - Info sul continente non disponibili 204
AF - Africa 129
OC - Oceania 16
Totale 15.063
Nazione #
US - Stati Uniti d'America 5.723
IT - Italia 1.456
GB - Regno Unito 1.211
RU - Federazione Russa 958
CN - Cina 863
SG - Singapore 803
IE - Irlanda 620
BR - Brasile 370
SE - Svezia 304
FR - Francia 289
DE - Germania 276
VN - Vietnam 253
UA - Ucraina 238
HK - Hong Kong 226
FI - Finlandia 147
KR - Corea 147
IN - India 100
BD - Bangladesh 97
ZA - Sudafrica 61
CA - Canada 52
TR - Turchia 49
MX - Messico 39
NL - Olanda 36
JP - Giappone 35
PL - Polonia 33
ES - Italia 31
AR - Argentina 28
NG - Nigeria 18
PK - Pakistan 17
AT - Austria 16
BE - Belgio 16
IQ - Iraq 16
AU - Australia 15
ID - Indonesia 15
EC - Ecuador 14
TW - Taiwan 12
CI - Costa d'Avorio 10
CL - Cile 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
GR - Grecia 8
VE - Venezuela 8
KE - Kenya 7
LT - Lituania 7
MY - Malesia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CH - Svizzera 6
CO - Colombia 6
EE - Estonia 6
IL - Israele 6
JO - Giordania 6
SN - Senegal 6
AM - Armenia 5
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
IR - Iran 5
PY - Paraguay 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AL - Albania 4
JM - Giamaica 4
LV - Lettonia 4
MA - Marocco 4
PE - Perù 4
CM - Camerun 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HN - Honduras 3
LK - Sri Lanka 3
NP - Nepal 3
RS - Serbia 3
SR - Suriname 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
Totale 14.848
Città #
Southend 1.081
Dallas 728
Dublin 618
Fairfield 498
Singapore 453
Ashburn 409
Siena 309
Santa Clara 296
Moscow 266
Milan 265
San Jose 264
Beijing 253
Menlo Park 252
Chandler 251
Woodbridge 231
Hong Kong 210
Wilmington 196
Jacksonville 185
Hefei 169
Seattle 169
Houston 163
Cambridge 143
Council Bluffs 142
Seoul 141
Ann Arbor 138
Los Angeles 112
Princeton 108
Florence 98
Rome 98
Helsinki 86
The Dalles 79
Nanjing 78
Ho Chi Minh City 76
New York 75
Lauterbourg 69
Hanoi 66
Johannesburg 58
Fremont 53
Columbus 49
Boardman 43
Munich 42
San Mateo 38
São Paulo 34
Bengaluru 30
Dearborn 30
Frankfurt am Main 27
London 27
San Diego 27
Shanghai 27
Tokyo 27
Buffalo 26
Naples 26
Izmir 25
Chicago 22
Nanchang 21
Orem 21
Redondo Beach 20
Düsseldorf 19
Shenyang 19
Abuja 18
Brooklyn 18
Figino 17
Turku 17
Chennai 16
Montreal 15
Tianjin 15
Warsaw 15
Bologna 14
Brussels 14
Guangzhou 14
Haiphong 14
Paris 13
San Francisco 13
Manchester 12
Mexico City 12
Nuremberg 12
Palermo 12
Vienna 12
Washington 12
Amsterdam 11
Bari 11
Cardiff 11
Hebei 11
Piscataway 11
Turin 11
Abidjan 10
Denver 10
Dong Ket 10
Kunming 10
L’Aquila 10
Norwalk 10
Redwood City 10
Rio de Janeiro 10
Brescia 9
Lappeenranta 9
Melbourne 9
Mogliano 9
Mumbai 9
Philadelphia 9
Toronto 9
Totale 9.980
Nome #
Ligandi TRPV1 519
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 413
Cytotoxic effects of cannabinoids on human HT-29 colorectal adenocarcinoma cells: different mechanisms of THC, CBD, and CB83 367
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 365
Synthesis of pyrazolo[1,5-a]pyrimidine ring as a possible bioisosteric replacement of the 5-(1H-pyrrol-1-yl)pyrazole scaffold 363
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 314
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors 307
Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators 300
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 284
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 278
Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening 271
Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist 261
Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity 260
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 257
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 254
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 254
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol 249
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 246
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors 245
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 243
Design, synthesis, and physicochemical and pharmacological profiling of 7‐Hydroxy-5-oxopyrazolo[4,3‐b]pyridine-6-carboxamide derivatives with antiosteoarthritic activity in vivo 241
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 241
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 236
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 236
3-Amino-alkylated indoles: Unexplored green products acting as anti-inflammatory agents 234
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 233
Active manganese dioxide promoted cyclization of ortho-(1H-pyrrol-1-yl)aryl and heteroaryl carboxylic acids to 5H-pyrrolo[1,2-a][3,1]benzoxazin-5-one derivatives 232
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides 229
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 229
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 226
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi 222
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 218
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 216
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 216
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 215
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 214
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 212
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations 210
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 209
Anti-addictive properties of COR659 – Additional pharmacological evidence and comparison with a series of novel analogues 208
TRPV1-FAAH-COX: The Couples Game in Pain Treatment 206
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors 203
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 200
HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies 199
Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway 196
Thiazolothiazepine Inhibitors of HIV-1 Integrase 194
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method 191
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile 181
Design, synthesis and in vitro experimental validation of novel TRPV4 antagonists inspired by labdane diterpenes 179
Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii 176
Polycondensed Heterocycles. Part 11: Preparation and Regioselective Reductions of 5-Phenyl-4H-pyrrolo[1,2-a][1]benzazepin-4-one 172
An approach to the stereo-controlled synthesis of polycyclic derivatives of L-4-thiazolidinecarboxilic acid active against HIV-1 integrase 170
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 168
Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse 162
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo 161
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 156
New synthesis of N1- and N2-substituted pyrazolo[4,3-b]pyridine-5-one derivatives as CB2 receptor ligands 153
Napthoxazepine Inhibitors of HIV-1 Integrase: Synthesis and Biological Evaluation 151
Synthesis of some novel 1-aryl-1H-1,2,3-triazole-4-carboxamides and ethyl 1-aryl-5-(1,2,3-triazol-1-yl)-1H-pyrazole-4-carboxylates 150
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor 139
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands 138
Targeting neuropathic pain: pathobiology, current treatment and peptidomimetics as a new therapeutic opportunity 137
Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors 132
GPR120/FFAR4 pharmacology: focus on agonists in Type 2 diabetes mellitus drug discovery 127
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 125
Old strategies and new perspectives in modulating the endocannabinoid system 123
Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity 113
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 107
Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain 17
Light-Controlled Modulation of the Endocannabinoid System: Photoswitchable Ligands for Cannabinoid and TRPV1 Receptors 10
Totale 15.063
Categoria #
all - tutte 46.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022970 0 121 97 102 64 41 50 55 45 113 96 186
2022/20231.150 81 88 177 136 100 225 45 92 91 29 60 26
2023/20241.133 58 24 92 63 63 236 363 36 17 40 28 113
2024/20252.156 59 98 230 127 247 145 98 134 178 114 207 519
2025/20265.136 390 779 575 586 876 192 581 165 169 261 164 398
2026/2027350 238 112 0 0 0 0 0 0 0 0 0 0
Totale 15.063